A judge in Essex County has dismissed New Jersey’s public nuisance claim against Purdue Pharma over its marketing of opioid drug Oxycontin, and ruled several other claims are limited by statute of limitations.

The ruling, issued Oct. 2, leaves intact the state’s claims that Purdue Pharma violated New Jersey’s Consumer Fraud Act by making false or misleading statements and engaged in unconscionable practices, and that it violated the state’s False Claims Act by inducing prescribers to write medically unnecessary prescriptions that the state paid for.